95
Participants
Start Date
October 31, 2016
Primary Completion Date
April 28, 2018
Study Completion Date
May 25, 2018
POMA
"Pomaglumetad (POMA) is a mGluR 2/3 partial agonist"
placebo
matching placebo tablets
New York University, New York
Columbia University, New York
University of Alabama, Birmingham, Birmingham
University of California, Los Angeles, Los Angeles
National Institute of Mental Health (NIMH)
NIH
New York State Psychiatric Institute
OTHER